An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease
Hepatobiliary Surgery and Nutrition · 2023-06 · 12 (3) · 386-403
DOI: 10.21037/hbsn-22-421 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hepatobiliary Surgery and Nutrition, 2023-06. Verfasst von Dan-Qin Sun und 47 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Jiangnan University Medical Center, Wuxi, China. Die Arbeit wurde bisher 89-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
With the rising global prevalence of fatty liver disease related to metabolic dysfunction, the association of this common liver condition with chronic kidney disease (CKD) has become increasingly evident. In 2020, the more inclusive term metabolic dysfunction-associated fatty liver disease (MAFLD) was proposed to replace the term non-alcoholic fatty liver disease (NAFLD). The observed association between MAFLD and CKD and our understanding that CKD can be a consequence of underlying metabolic dysfunction support the notion that individuals with MAFLD are at higher risk of having and developing CKD compared with those without MAFLD. However, to date, there is no appropriate guidance on CKD in individuals with MAFLD. Furthermore, there has been little attention paid to the link between MAFLD and CKD in the Nephrology community. Methods and Results: Using a Delphi-based approach, a multidisciplinary panel of 50 international experts from 26 countries reached a consensus on some of the open research questions regarding the link between MAFLD and CKD.
Conclusions
This Delphi-based consensus statement provided guidance on the epidemiology, mechanisms, management and treatment of MAFLD and CKD, as well as the relationship between the severity of MAFLD and risk of CKD, which establish a framework for the early prevention and management of these two common and interconnected diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Jiangnan University Medical Center, Wuxi, China.
- Affiliated Wuxi Clinical College of Nantong University, Wuxi, China.
- Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
- Southampton National Institute for Health and Care Research Biomedical Research Centre, University Hospital Southampton, and Southampton General Hospital, University of Southampton, Southampton, UK.
- Department of Renal Medicine, University College London, London, UK.
- Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong, China.
Zitieren
APA
Sun, D. Q., Targher, G., Byrne, C. D., Wheeler, D. C., Wong, V. W., Fan, J. G., Tilg, H., Yuan, W. J., Wanner, C., Gao, X., Long, M. T., Kanbay, M., Nguyen, M. H., Navaneethan, S. D., Yilmaz, Y., Huang, Y., Gani, R. A., Marzuillo, P., Boursier, J., …, & Zheng, M. H. (2023). An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease. Hepatobiliary Surgery and Nutrition, 12(3), 386-403. https://doi.org/10.21037/hbsn-22-421
Vancouver
Sun DQ, Targher G, Byrne CD, Wheeler DC, Wong VW, Fan JG, et al. An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease. Hepatobiliary Surgery and Nutrition. 2023;12(3):386-403. doi:10.21037/hbsn-22-421
BibTeX
@article{Sun2023,
author = {Sun, Dan-Qin and Targher, Giovanni and Byrne, Christopher D and Wheeler, David C and Wong, Vincent Wai-Sun and Fan, Jian-Gao and Tilg, Herbert and Yuan, Wei-Jie and Wanner, Christoph and Gao, Xin and Long, Michelle T and Kanbay, Mehmet and Nguyen, Mindie H and Navaneethan, Sankar D and Yilmaz, Yusuf and Huang, Yuli and Gani, Rino A and Marzuillo, Pierluigi and Boursier, Jérôme and Zhang, Huijie and Jung, Chan-Young and Chai, Jin and Valenti, Luca and Papatheodoridis, George and Musso, Giovanni and Wong, Yu-Jun and El-Kassas, Mohamed and Méndez-Sánchez, Nahum and Sookoian, Silvia and Pavlides, Michael and Duseja, Ajay and Holleboom, Adriaan G and Shi, Junping and Chan, Wah-Kheong and Fouad, Yasser and Yang, Junwei and Treeprasertsuk, Sombat and Cortez-Pinto, Helena and Hamaguchi, Masahide and Romero-Gomez, Manuel and Al Mahtab, Mamun and Ocama, Ponsiano and Nakajima, Atsushi and Dai, Chunsun and Eslam, Mohammed and Wei, Lai and George, Jacob and Zheng, Ming-Hua},
title = {An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease},
journal = {Hepatobiliary Surgery and Nutrition},
year = {2023},
volume = {12},
number = {3},
pages = {386--403},
doi = {10.21037/hbsn-22-421}
}
EUVIMED